Observational Study
Copyright ©The Author(s) 2017.
World J Clin Oncol. Aug 10, 2017; 8(4): 351-359
Published online Aug 10, 2017. doi: 10.5306/wjco.v8.i4.351
Table 3 Patient characteristics
Patient numberGenderAgeTumorUnderlying liver functionFLR/BWR before PVE, %FLR/BWR before ALPPS-1, %FLR/BWR before ALPPS-2, %ALPPS-2 day 5 Bilirubin, µmol/LALPPS-2 day 5 PT, %Dindo-Clavien classificationComplications(by order of appearance)
1M68pCCACholestasis0.350.591.0518245VIntraoperative blood transfusion, intra-abdominal abscess, pleural effusion, death due to peritonitis caused by bowel perforation
2M70iCCA-0.330.580.824360IIIntraoperative blood transfusion, transitory ascites
3M55CRLMFNH0.450.550.764341IIIntraoperative blood transfusion
4F66pCCACholestasis0.430.661.214473IIITransitory ascites and intra-abdominal abscess
5F59CRLMSOS and steatosis0.420.801.231069IIIntraoperative blood transfusion, urinary infection
6F53CRLMDystrophy0.520.620.898750IVIntraoperative blood transfusion, internal hemorrhage, transitory hepatic insufficiency, infected ascites, septic choc, and intra-abdominal abscess
7M61CRLM-0.460.831.141367IIIntraoperative blood transfusion, transitory chylous ascites